Morning Overview on MSN
New nanoparticle shot could deliver mRNA to stop type 1 diabetes
Scientists at the University of Chicago have built a lipid nanoparticle system that delivers mRNA directly to ...
News-Medical.Net on MSN
Long COVID taste loss tied to reduced expression of key taste genes
By Dr. Liji Thomas, MD Even after the virus disappears, some people continue to experience altered taste. New research ...
A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in ...
Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body's ability to ...
Naked mRNA administration in the testes rescues sperm function, demonstrating a potential therapeutic approach for genetic male infertility.
The Nation (PK) on MSN
Breast cancer's pathobiology
One disease that arises from disruptions in the cell cycle is cancer. After a series of events, a normal cell begins to divide uncontrollably and becomes a tumour cell. Breast tumours are a complex ...
Live webcasts can be accessed on the investor relations page of CAMP4’s website at A replay of the webcasts will be archived on the CAMP4 website ...
Lipid nanoparticle-delivered messenger RNA encoding anti-PD-L1 nanobodies has reduced tumour growth in sporadic and colitis-associated colorectal cancer models, with quadruple constructs that ...
Researchers developed an mRNA delivery system designed to improve embryo implantation. This approach could enhance ART ...
Researchers identify a reduction in the PLCβ2 protein as the cause for long-term sweet, bitter, and umami taste loss in post-COVID patients.
Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to ...
Therna Biosciences, a biotechnology company pioneering programmable RNA therapeutics, today announced a collaboration with Charles River to advance single-patient RNA medicines for individuals with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果